These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
725 related items for PubMed ID: 29596361
21. Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin. Harmankaya O, Eran A. Ren Fail; 2002 Mar; 24(2):245-7. PubMed ID: 12071600 [Abstract] [Full Text] [Related]
22. Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial. Gaillard CA, Bock AH, Carrera F, Eckardt KU, Van Wyck DB, Bansal SS, Cronin M, Meier Y, Larroque S, Roger SD, Macdougall IC. PLoS One; 2016 Mar; 11(6):e0157063. PubMed ID: 27276035 [Abstract] [Full Text] [Related]
23. Review of available intravenous iron preparations in hemodialysis. Palmer K, Cameron K, Battistella M. CANNT J; 2013 Mar; 23(2):51-4; quiz 55-6. PubMed ID: 24069699 [No Abstract] [Full Text] [Related]
24. Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial. Nissenson AR, Lindsay RM, Swan S, Seligman P, Strobos J. Am J Kidney Dis; 1999 Mar; 33(3):471-82. PubMed ID: 10070911 [Abstract] [Full Text] [Related]
25. Intravenous versus oral iron therapy for postpartum anaemia. Bhandal N, Russell R. BJOG; 2006 Nov; 113(11):1248-52. PubMed ID: 17004982 [Abstract] [Full Text] [Related]
26. Iron Fortified Complementary Foods Containing a Mixture of Sodium Iron EDTA with Either Ferrous Fumarate or Ferric Pyrophosphate Reduce Iron Deficiency Anemia in 12- to 36-Month-Old Children in a Malaria Endemic Setting: A Secondary Analysis of a Cluster-Randomized Controlled Trial. Glinz D, Wegmüller R, Ouattara M, Diakité VG, Aaron GJ, Hofer L, Zimmermann MB, Adiossan LG, Utzinger J, N'Goran EK, Hurrell RF. Nutrients; 2017 Jul 14; 9(7):. PubMed ID: 28708072 [Abstract] [Full Text] [Related]
27. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. Khalafallah A, Dennis A, Bates J, Bates G, Robertson IK, Smith L, Ball MJ, Seaton D, Brain T, Rasko JE. J Intern Med; 2010 Sep 14; 268(3):286-95. PubMed ID: 20546462 [Abstract] [Full Text] [Related]
31. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose. Schatz U, Illigens BM, Siepmann T, Arneth B, Siegert G, Siegels D, Heigl F, Hettich R, Ramlow W, Prophet H, Bornstein SR, Julius U. Atheroscler Suppl; 2015 May 14; 18():199-208. PubMed ID: 25936327 [Abstract] [Full Text] [Related]
32. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. Li H, Wang SX. Blood Purif; 2008 May 14; 26(2):151-6. PubMed ID: 18212498 [Abstract] [Full Text] [Related]
33. FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Macdougall IC, Bock AH, Carrera F, Eckardt KU, Gaillard C, Van Wyck D, Roubert B, Nolen JG, Roger SD, FIND-CKD Study Investigators. Nephrol Dial Transplant; 2014 Nov 14; 29(11):2075-84. PubMed ID: 24891437 [Abstract] [Full Text] [Related]
34. Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy. Adhikary L, Acharya S. JNMA J Nepal Med Assoc; 2011 Nov 14; 51(183):133-6. PubMed ID: 22922860 [Abstract] [Full Text] [Related]
35. Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients. Dittrich E, Schillinger M, Sunder-Plassmann G, Hörl WH, Vychytil A. Perit Dial Int; 2002 Nov 14; 22(1):60-6. PubMed ID: 11929146 [Abstract] [Full Text] [Related]
36. The FIND-CKD study--a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale. Macdougall IC, Bock A, Carrera F, Eckardt KU, Gaillard C, Van Wyck D, Roubert B, Cushway T, Roger SD, FIND-CKD Study Investigators. Nephrol Dial Transplant; 2014 Apr 14; 29(4):843-50. PubMed ID: 24170814 [Abstract] [Full Text] [Related]
37. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial. Giancaspro V, Nuzziello M, Pallotta G, Sacchetti A, Petrarulo F. J Nephrol; 2000 Apr 14; 13(6):444-9. PubMed ID: 11132761 [Abstract] [Full Text] [Related]
38. Intravenous ferric carboxymaltose for iron deficiency anemia in dialysis patients: Effect of a new protocol adopted for a hemodialysis limited assistance center. Gobbi L, Scaparrotta G, Rigato M, Cattarin L, Qassim L, Carraro G, Rossi B, Calò LA. Ther Apher Dial; 2020 Dec 14; 24(6):642-647. PubMed ID: 32154642 [Abstract] [Full Text] [Related]
39. Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD: A Randomized Trial. Womack R, Berru F, Panwar B, Gutiérrez OM. Clin J Am Soc Nephrol; 2020 Sep 07; 15(9):1251-1258. PubMed ID: 32694162 [Abstract] [Full Text] [Related]
40. Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study. Valério de Azevedo S, Maltez C, Lopes AI. Scand J Gastroenterol; 2017 Jan 07; 52(1):29-33. PubMed ID: 27576956 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]